Investor List:

Top Diagnostics Series A Investors in Canada (8)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Hardware (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Hardware (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Therapeutics (Series B), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Aldi Agaj, Managing Partner at AAK TELE-SCIENCE, INC.
Aldi Agaj
AAK TELE-SCIENCE, INC.·Managing Partner
Sweet spot: $2.5M
Range: $500K - $6.0M
Investors in Egypt, Investors in New Zealand, Investors in Ukraine, Investors in Portugal, Investors in Spain, Investors in France, Investors in Australia, Investors in Netherlands, Investors in Germany, Investors in Israel, Investors in California, Investors in Belgium, Investors in Italy, Investors in Canada, Investors in Beijing, Investors in Argentina
Investors in Smart Cities/UrbanTech (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Smart Cities/UrbanTech (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Smart Cities/UrbanTech (Pre-seed), Investors in AR/VR (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in AR/VR (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Education (Pre-seed), Investors in BioTech (Pre-seed), Investors in Education (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Education (Pre-seed), Investors in BioTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Smart Cities/UrbanTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in FinTech (Pre-seed), Investors in FinTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in FinTech (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Education (Pre-seed), Investors in DeepTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in FinTech (Pre-seed), Investors in Smart Cities/UrbanTech (Seed), Investors in Diagnostics (Seed), Investors in Smart Cities/UrbanTech (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Smart Cities/UrbanTech (Seed), Investors in AR/VR (Seed), Investors in DeepTech (Seed), Investors in BioTech (Seed), Investors in AR/VR (Seed), Investors in EnergyTech (Seed), Investors in EnergyTech (Seed), Investors in Education (Seed), Investors in Education (Seed), Investors in AgTech (Seed), Investors in AR/VR (Seed), Investors in Education (Seed), Investors in BioTech (Seed), Investors in DeepTech (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in Smart Cities/UrbanTech (Seed), Investors in AgTech (Seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in FinTech (Seed), Investors in AI (Seed), Investors in Diagnostics (Seed), Investors in FinTech (Seed), Investors in AI (Seed), Investors in AR/VR (Seed), Investors in DeepTech (Seed), Investors in Education (Seed), Investors in AgTech (Seed), Investors in EnergyTech (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in FinTech (Seed), Investors in Smart Cities/UrbanTech (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Smart Cities/UrbanTech (Series A), Investors in Diagnostics (Series A), Investors in AR/VR (Series A), Investors in Smart Cities/UrbanTech (Series A), Investors in Education (Series A), Investors in AR/VR (Series A), Investors in EnergyTech (Series A), Investors in DeepTech (Series A), Investors in Education (Series A), Investors in AR/VR (Series A), Investors in Education (Series A), Investors in EnergyTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in AgTech (Series A), Investors in AgTech (Series A), Investors in EnergyTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Smart Cities/UrbanTech (Series A), Investors in FinTech (Series A), Investors in AI (Series A), Investors in FinTech (Series A), Investors in Diagnostics (Series A), Investors in FinTech (Series A), Investors in AI (Series A), Investors in AR/VR (Series A), Investors in AgTech (Series A), Investors in DeepTech (Series A), Investors in EnergyTech (Series A), Investors in Education (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in FinTech (Series A), Investors in Canada (Other Lists), Investors in LatAm (Latin America) (Other Lists), Investors in Israel (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of JJ Richa, Managing Partner at Pismo Ventures
JJ Richa
Pismo Ventures·Managing Partner
Sweet spot: $500K
Range: $50K - $1M
Investors in Canada, Investors in United States
Investors in Diagnostics (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in IoT (Pre-seed), Investors in E-commerce (Pre-seed), Investors in SMB Software (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in FinTech (Pre-seed), Investors in AI (Pre-seed), Investors in SaaS (Pre-seed), Investors in Cybersecurity (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in SMB Software (Pre-seed), Investors in IoT (Pre-seed), Investors in Web3/Blockchain (Pre-seed), Investors in E-commerce (Pre-seed), Investors in AI (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in Diagnostics (Seed), Investors in Enterprise Applications (Seed), Investors in Cybersecurity (Seed), Investors in SMB Software (Seed), Investors in IoT (Seed), Investors in E-commerce (Seed), Investors in Diagnostics (Seed), Investors in Web3/Blockchain (Seed), Investors in FinTech (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Cybersecurity (Seed), Investors in Enterprise Applications (Seed), Investors in IoT (Seed), Investors in SMB Software (Seed), Investors in Web3/Blockchain (Seed), Investors in E-commerce (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in FinTech (Seed), Investors in Diagnostics (Series A), Investors in IoT (Series A), Investors in Enterprise Applications (Series A), Investors in Cybersecurity (Series A), Investors in SMB Software (Series A), Investors in E-commerce (Series A), Investors in Web3/Blockchain (Series A), Investors in Diagnostics (Series A), Investors in FinTech (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Cybersecurity (Series A), Investors in Enterprise Applications (Series A), Investors in IoT (Series A), Investors in SMB Software (Series A), Investors in E-commerce (Series A), Investors in Web3/Blockchain (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in FinTech (Series A), Investors in Canada (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists)
Photo of Eric Blondeel, Venture Partner at Pioneer Fund
Eric Blondeel
Pioneer Fund·Venture Partner
Sweet spot: $250K
Range: $200K - $300K
Investors in Canada
Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Canada (Other Lists)
Photo of Chris Angelatos, Associate at Esplanade HealthTech Ventures
Chris Angelatos
Sweet spot: $2.0M
Range: $500K - $7.5M
Investors in Israel, Investors in Europe, Investors in United States, Investors in Canada
Investors in Parenting/Families (Seed), Investors in Parenting/Families (Seed), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Seed), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Medical Devices (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Parenting/Families (Seed), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Parenting/Families (Series A), Investors in Parenting/Families (Series A), Investors in Wellness & Fitness (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Parenting/Families (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Parenting/Families (Series B), Investors in Parenting/Families (Series B), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Wellness & Fitness (Series B), Investors in Consumer Health (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Parenting/Families (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in British Columbia (Other Lists), Investors in Canada (Other Lists), Investors in Israel (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Photo of Soyoung Park, General Partner at 1004 Venture Partners
Soyoung Park
1004 Venture Partners·General Partner
Sweet spot: $500K
Range: $100K - $10.0M
Investors in South Korea, Investors in Japan, Investors in Europe, Investors in United Kingdom, Investors in Canada, Investors in United States
Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Generative Tech/AI (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Generative Tech/AI (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Generative Tech/AI (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in Robotics (Series A), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Robotics (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Wellness & Fitness (Series B), Investors in Generative Tech/AI (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Robotics (Series B), Investors in Consumer Health (Series B), Investors in Canada (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in Female Investors (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Diverse Investors (Other Lists)
Photo of Mack Luby, Associate at Mystic Ventures
Mack Luby
Mystic Ventures·Associate
Sweet spot: $250K
Range: $50K - $1M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Drug Delivery (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Therapeutics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Drug Delivery (Series A), Investors in AI (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Canada (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists)
SA
Sarah Applebaum
Sweet spot: $4.5M
Range: $3.0M - $6.0M
Investors in United States, Investors in Canada